FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
PD Dr. Fabian Müller
Orcid ID:
0000-0001-5487-5839
List of publications:
BibTeX-Download
Medizinische Fakultät
Department of Medicine 5 – Haematology and Oncology
Professur für CAR-T-Zell-Therapie
Project Leads
(2)
Publications
(56)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus. (2024)
Taubmann J, Müller F, Mutlu MY, Völkl S, Aigner M, Bozec A, Mackensen A, et al.
Journal article, Review article
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up. (2024)
Müller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, Völkl S, Aigner M, et al.
Journal article
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. (2024)
Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, et al.
Journal article, Review article
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies (2024)
Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kleyer A, Gary R, et al.
Journal article, Letter
Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply. (2024)
Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kretschmann S, Atzinger A, et al.
Journal article
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024)
Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al.
Journal article
Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy (2023)
Nunez D, Patel D, Volkov J, Wong S, Vorndran Z, Müller F, Aigner M, et al.
Journal article
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response (2023)
Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, et al.
Journal article
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany (2023)
Bader P, Rossig C, Hutter M, Ayuk FA, Baldus CD, Bücklein VL, Bonig H, et al.
Journal article
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023)
Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al.
Journal article, Letter
‹
1
2
3
4
...
6
›